Jan 15, 2020
Anti-VEGF Therapy in Patients with Neovascular AMD
American Academy of Ophthalmology, Ghazala A Datoo O'Keefe, MD
Retina/Vitreous
Learning Plan
CME
2.5 Self-Assessment AMA PRA Category 1 Credits™
This learning plan, based on IRIS Registry measure IRIS45: Exudative Age-Related Macular Degeneration: Loss of Visual Acuity, reviews the impact of anti-VEGF injections in patients with wet age-related macular degeneration (AMD), including genetic predictive biomarkers of anti-VEGF treatment responses.